Metronidazole | Actavis Pharma, Inc. Breastfeeding

It is recommended to breastfeed exclusively for six months and then while introducing to other food sources extend it to twelve months. In this duration most mothers will need help of some sort of medication, It could be for short term like could and flue or it could be something chronic like Arthritis or Diabetes and here comes the question of safety of medication in use. In this post we will figure out what is Metronidazole | Actavis Pharma, Inc. and whether its safe to use Metronidazole | Actavis Pharma, Inc. while nursing or not.

What is Metronidazole | Actavis Pharma, Inc. used for?

Metronidazole Topical Lotion is indicated for topical application in treatment of inflammatory papules and pustules of rosacea.

Metronidazole | Actavis Pharma, Inc. while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Metronidazole | Actavis Pharma, Inc. safe for breastfeeding
Active ingredient in Metronidazole | Actavis Pharma, Inc. is Metronidazole and based on our analysis of Metronidazole it appears that using Metronidazole | Actavis Pharma, Inc. is safe in breastfeeding. Below is analysis of Metronidazole while breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
NURSING MOTHERS After oral administration, metronidazole is secreted in breast milk in concentrations similar to those found in the plasma. Even though blood levels are significantly lower with topically applied metronidazole than those achieved after oral administration of metronidazole, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Metronidazole | Actavis Pharma, Inc. Breastfeeding Analsys

Metronidazole while Breastfeeding


CAS Number: 443-48-1

Excreted into breast milk in a non-significant clinical amount. Not problems on breastfed infants of treated mothers were found. Plasma levels were low or undetectable in those infants. For a mother's dose of 400 mg three times-a-day, the intake of a breastfed infant would be less than 10% of the usual daily pediatric dose, whenever the breast-feed is done within 2-3 hours of mother's intake. Widely used for treatment of Giardia lamblia infections, even in small infants, without adverse effects reported. Metronidazole may produce a red discoloration of corporal fluids and bitter flavor of the milk with no harm effect on the child.

Metronidazole | Actavis Pharma, Inc. Breastfeeding Analsys - 2

Metronidazole while Breastfeeding

CAS Number: 443-48-1

Metronidazole | Actavis Pharma, Inc. and breastfeeding

With maternal intravenous and oral therapy, breastfed infants receive metronidazole in doses that are less than those used to treat infections in infants, although the active metabolite adds to the total infant exposure. Plasma levels of the drug and metabolite are measurable, but less than maternal plasma levels. Case reports of candidal infections and diarrhea have been reported, and a comparative trial suggested that oral and rectal colonization with might be more common in infants exposed to metronidazole. Neither topical nor vaginal metronidazole have been studied during breastfeeding. After vaginal administration, plasma levels are less than 2% of those after a 500 mg oral dose. After topical administration, blood levels are about 1% of the peak plasma levels after a 250 mg oral dose. Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.[1] Because of the well demonstrated genotoxicity and mutagenicity in bacteria, carcinogenicity in animals, and possible mutagenicity in humans,[2][3] concern has been raised about exposure of healthy infants to metronidazole via breastmilk.[4] The relevance of these findings has been questioned and no definitive study has yet been performed in humans.[3][5] Opinions vary among experts on the advisability of using metronidazole during longer-term therapy while breastfeeding, but some sources recommend discontinuing breastfeeding for 12 to 24 hours after single-dose maternal treatment.[4][6] Other drugs are available for some conditions that metronidazole is used to treat. Topical or vaginal use of metronidazole during breastfeeding is unlikely to be of concern, although the manufacturer of one vaginal product recommends not breastfeeding during treatment and for 2 days after the last dose.

Is Metronidazole | Actavis Pharma, Inc. safe while breastfeeding

What if I already have used Metronidazole | Actavis Pharma, Inc.?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Metronidazole | Actavis Pharma, Inc. and have used it then do not panic as Metronidazole | Actavis Pharma, Inc. is mostly safe in breastfeeding and should not cause any harm to your baby.

I am nursing mother and my doctor has suggested me to use Metronidazole | Actavis Pharma, Inc., is it safe?

Usage of Metronidazole | Actavis Pharma, Inc. is safe for nursing mothers and baby, No worries.

If I am using Metronidazole | Actavis Pharma, Inc., will my baby need extra monitoring?


Who can I talk to if I have questions about usage of Metronidazole | Actavis Pharma, Inc. in breastfeeding?

National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week